DK0946149T3 - Homogene præformuleringer indeholdende steroider i høj koncentration til fremstilling af lavdoserede faste og halvfaste farmaceutiske præparater - Google Patents

Homogene præformuleringer indeholdende steroider i høj koncentration til fremstilling af lavdoserede faste og halvfaste farmaceutiske præparater

Info

Publication number
DK0946149T3
DK0946149T3 DK97953625T DK97953625T DK0946149T3 DK 0946149 T3 DK0946149 T3 DK 0946149T3 DK 97953625 T DK97953625 T DK 97953625T DK 97953625 T DK97953625 T DK 97953625T DK 0946149 T3 DK0946149 T3 DK 0946149T3
Authority
DK
Denmark
Prior art keywords
steroid
solid
adjuvant
semi
pharmaceutical preparations
Prior art date
Application number
DK97953625T
Other languages
English (en)
Inventor
Detlef Grawe
Peter Hoesel
Peter Moellmann
Carsten Timpe
Michael Dittgen
Klaus Matthey
Original Assignee
Jenapharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jenapharm Gmbh filed Critical Jenapharm Gmbh
Application granted granted Critical
Publication of DK0946149T3 publication Critical patent/DK0946149T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK97953625T 1996-12-16 1997-12-15 Homogene præformuleringer indeholdende steroider i høj koncentration til fremstilling af lavdoserede faste og halvfaste farmaceutiske præparater DK0946149T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19652196A DE19652196A1 (de) 1996-12-16 1996-12-16 Homogene steroidhaltige Präformulierungen zur Herstellung niedrigdosierter fester und halbfester pharmazeutischer Zubereitungen
PCT/DE1997/002915 WO1998026762A1 (de) 1996-12-16 1997-12-15 Homogene, steroide in hoher konzentration enthaltende, präformulierungen zur herstellung niedrigdosierter fester und halbfester pharmazeutischer zubereitungen

Publications (1)

Publication Number Publication Date
DK0946149T3 true DK0946149T3 (da) 2002-10-07

Family

ID=7814809

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97953625T DK0946149T3 (da) 1996-12-16 1997-12-15 Homogene præformuleringer indeholdende steroider i høj koncentration til fremstilling af lavdoserede faste og halvfaste farmaceutiske præparater

Country Status (13)

Country Link
US (2) US6290931B1 (da)
EP (1) EP0946149B1 (da)
JP (1) JP2001506639A (da)
AT (1) ATE219357T1 (da)
AU (1) AU5748098A (da)
CA (1) CA2275626C (da)
CL (1) CL2004000976A1 (da)
DE (2) DE19652196A1 (da)
DK (1) DK0946149T3 (da)
ES (1) ES2179385T3 (da)
PT (1) PT946149E (da)
RU (1) RU2178694C2 (da)
WO (1) WO1998026762A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19906152B4 (de) 1999-02-10 2005-02-10 Jenapharm Gmbh & Co. Kg Wirkstoffhaltige Laminate für Transdermalsysteme
EP1171091A1 (de) * 1999-04-16 2002-01-16 Jenapharm GmbH & Co. KG Pharmazeutische oder kosmetische zusammensetzungen zur lokalen, intradermalen applikation von estrogenen
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
EP1216713A1 (en) * 2000-12-20 2002-06-26 Schering Aktiengesellschaft Compositions of estrogen-cyclodextrin complexes
US20050220825A1 (en) * 2004-03-10 2005-10-06 Adrian Funke Molecular dispersions of drospirenone
DE102006026578B4 (de) 2006-06-08 2009-01-08 Lts Lohmann Therapie-Systeme Ag Wirkstoffpartikelhaltiges Transdermales Therapeutisches System mit erhöhtem Wirkstofffluss und Verfahren zu seiner Herstellung sowie Verwendung
DE102008037025C5 (de) 2008-08-08 2016-07-07 Jesalis Pharma Gmbh Verfahren zur Herstellung kristalliner Wirkstoff-Mikropartikel bzw. einer Wirkstoffpartikel-Festkörperform

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4631284A (en) * 1984-11-19 1986-12-23 Mallinckrodt, Inc. Acetaminophen compositions containing low doses of chlorpheniramine maleate, method for preparing same and tablets formed therefrom
IE67345B1 (en) * 1991-03-12 1996-03-20 Akzo Nv Low dose dry pharmaceutical preparations
IT1252867B (it) * 1991-12-31 1995-06-28 Gentili Ist Spa Composizioni farmaceutiche contenenti progesterone ad elevata biodisponibilita'
CA2115065C (en) * 1992-06-12 2000-10-03 Kiyoyuki Sakon Ultrafine particle powder for inhalation and method for production thereof
KR100208979B1 (ko) * 1992-06-12 1999-07-15 야스이 쇼사꾸 기도내 투여용 제제
US5395627A (en) * 1992-09-04 1995-03-07 Akzo N.V. Pharmaceutical granulate
DE4426709A1 (de) * 1994-07-20 1996-01-25 Schering Ag Steroidale Sexualhormone enthaltende feste Arzneiformen

Also Published As

Publication number Publication date
ES2179385T3 (es) 2003-01-16
EP0946149B1 (de) 2002-06-19
DE59707573D1 (de) 2002-07-25
AU5748098A (en) 1998-07-15
EP0946149A1 (de) 1999-10-06
JP2001506639A (ja) 2001-05-22
DE19652196A1 (de) 1998-06-18
CA2275626C (en) 2005-02-15
PT946149E (pt) 2002-11-29
RU2178694C2 (ru) 2002-01-27
ATE219357T1 (de) 2002-07-15
US6290931B1 (en) 2001-09-18
WO1998026762A1 (de) 1998-06-25
US20020119103A1 (en) 2002-08-29
CL2004000976A1 (es) 2005-01-21
CA2275626A1 (en) 1998-06-25

Similar Documents

Publication Publication Date Title
Chew et al. Effect of amino acids on the dispersion of disodium cromoglycate powders
DK200000266A (da) Farmaceutisk sammensætning indeholdende en opløsning af cyclosporin.
DE69636177T2 (de) Umhüllung kleiner Partikel
ATE77946T1 (de) Injizierbares langwirkendes mikroteilchenpr|parat zur verabreichung entzuendungshemmender mittel.
JPH0687758A (ja) Ｌｈｒｈホルモンおよびその類似体を徐々に放出する微小球体の製造方法と、その微小球体と、それを含む製剤
AU5504599A (en) Quick release pharmaceutical compositions of drug substances
Momin et al. Manipulation of spray-drying conditions to develop dry powder particles with surfaces enriched in hydrophobic material to achieve high aerosolization of a hygroscopic drug
CA2125685A1 (en) Powders for inhalation and process for preparing them
EP0952821A1 (en) Processes for spray drying aqueous suspensions of hydrophobic drugs with hydrophilic excipients and compositions prepared by such processes
MXPA04004726A (es) Composiciones farmaceuticas en forma particulada.
PT744941E (pt) Processo para preparar formulacoes farmaceuticas de particulas finas
EP0896823A1 (en) Improved stabilization of prostaglandin drug
CA2430318A1 (en) Powder formulation and method for producing the same
DK0946149T3 (da) Homogene præformuleringer indeholdende steroider i høj koncentration til fremstilling af lavdoserede faste og halvfaste farmaceutiske præparater
Chow et al. A study of the mechanisms of wet spherical agglomeration of pharmaceutical powders
DE60023547T3 (de) PARTIKEL ZUR INHALATION: Herstellungsmethode
Uchida et al. Microencapsulation of ovalbumin in poly (lactide-co-glycolide) by an oil-in-oil (o/o) solvent evaporation method
WO1993020138A3 (en) Polymer system containing a partially soluble compound
Philip et al. Effect of surface treatment on the respirable fractions of PLGA microspheres formulated for dry powder inhalers
JPH11130659A (ja) 水性懸濁医薬品組成物
US3600326A (en) Preparation of hydrophobic silica and use thereof
Habib et al. Improved dissolution of indomethacin in coprecipitates with phospholipids-I
GB2130588B (en) Micronised 2a-cyano-4a,5a-epoxy-3-oxo steroids
JP2506812B2 (ja) 水分散性の良いビタミンｅ含有粉末
JPS571457A (en) Composition for separating blood serum or plasma